Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 948-955

  Chen, Ji Li ^a   Dunbar, P Rod ^a   Gileadi, Uzi ^a   Jäger, Elke ^b   Gnjatic, Sacha ^c   Nagata, Yasuhiro ^c   Stockert, Elisabeth ^c   Panicali, Dennis L ^d   Chen, Yao Tseng ^e   Knuth, Alexander ^b   Old, Lloyd J ^c   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b KRANKENHAUS NORDWEST   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Therion Biologics Corporation   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; PROTEASOME; PROTEASOME INHIBITOR; TUMOR ANTIGEN;

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LYMPHOCYTE CLONE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0034661697     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.948     Document Type: Article

References (22)

1. Boon, T., and L. J. Old. 1997. Cancer tumor antigens. Curr. Opin. Immunol. 9:681.
2. Old, L. J., and Y. T. Chen. 1998. New paths in human cancer serology. J. Exp. Med. 187:1163.
3. Chen, Y. T., M. J. Scanlan, U. Sahin, O. Tureci, A. O. Gure, S. Tsang, B. Williamson, E. Stocken, M. Pfreundschuh, and L. J. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94:1914.
4. Jäger, E., Y. Nagata, S. Gnjatic, H. Wada, E. Stocken, J. Karbach, P. R. Dunbar, S. Y. Lee, A. Jungbluth, D. Jäger, et al. 2000. Monitoring CDS T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc. Natl. Acad Sci. USA 97:4760.
5. Jäger, E., Y. T. Chen, J. W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jager, M. Arand, H. Wada, Y. Noguchi, E. Stocken, et al. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187:265.
6. Valmori, D., U. Gileadi, C. Servis, P. R. Dunbar, J.-C. Cerottini, P. Romero, V. Cerundolo, and F. Levy. 1999. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 189:895.
7. Morel, S., F. Levy, O. Burlet-Schiltz, F. Brasseur, M. Probst-Kepper, A.-L. Peitrequin, B. Monsarrat, R. Van Velthoven, J.-C. Cerottini, T. Boon, et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12:107.
8. Dunbar, P. R., J.-L. Chen, D. Chao, N. Rust, H. Teisserenc, G. Ogg, P. Romero. P. Weynants, and V. Cerundolo. 1999. Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J. Immunol. 162:6959.
9. Chen, W., J. W. Yewdell, R. L. Levine, and J. R. Bennink. 1999. Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class 1-restricted viral determinants. J. Exp. Med. 189:1757.
10. Altman, J. D., P. Moss, P. Goulder, D. H. Barouch, W. M. McHeyzer, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
11. Dunbar, P. R., G. S. Ogg, J. Chen, N. Rust, P. van der Bruggen, and V. Cerundolo. 1998. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8:413.
12. Gileadi, U., H. Moins-Teisserenc, I. Correa, B. L. Booth, D. P. R. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163:6045.
13. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345:449.
14. Cerundolo, V., A. Kelly, T. Elliott, J. Trowsdale, and A. Townsend. 1995. Genes encoded in the MHC affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25:554.
15. Kittlesen, D., L. Thompson, P. Gulden, J. Skipper, T. Colella, J. Shabanowitz, D. Hunt, V. Engelhard, and C. J. Slingluff. 1998. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J. Immunol. 162: 2099.
16. Parker, K. C., M. A. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerink, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule. HLA-A2. J. Immunol. 149:3580.
17. van Kaer, L., P. Aston-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. Rock, A. Goldberg, P. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral specific T cell response in LMP2 mutant mice. Immunity 1:533.
18. Sewell, A. K., D. Price, H. Teisserenc, B. Booth, U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162: 7075.
19. Restifo, N., F. Esquivel, Y. Kawakami, J. Yewdell, J. Mule, S. Rosenberg, and J. Bennink. 1993 Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
20. Vijh, S., I. Pilip, and E. Pamer. 1998. Effect of antigen-processing efficiency on in vivo T cell response magnitudes. J. Immunol. 160:3971.
21. Valmori, D., J. F. Fonteneau, C. M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J. C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160:1750.
22. Valmori, D., F. Levy, I. Miconnet, P. Zajac, G. Spagnoli, D. Rimoldi, D. Lienard, V. Cerundolo, J. Cerottini, and P. Romero. 2000. Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A related peptide analogue. J. Immunol. 164:1125.